Skip to main content

Closed

CCCC: C4 Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

51thpctl

Volume

0.59×avg

Market Cap

384.77MUSD

P/E Ratio

-3.1TTM

Div Yield

-ann

C4 Therapeutics, Inc.

CCCCNASDAQ Global Select·USD·Closed

C4 Therapeutics, Inc.

CCCCNASDAQ·USD·Closed

$3.48

−4.92%

$3.48

−$0.18 (4.92%)

52W Range

51thpctl

Volume

0.59×avg

Mkt Cap

384.77MUSD

P/E

-3.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings